tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 116 are a BUY (95.87%), 5 are a HOLD (4.13%).
Analyst Geulah Livshits works at CHARDAN CAPITAL with a stock forecast success ratio of 35.86% fulfilled within 108.54 days on average.
Geulah Livshits’s has documented 232 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 22-Feb-2024.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $46 was fulfilled within 1 day with a profit of $13.97 (43.62%) receiving and performance score of 436.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
89
$33.34 (59.90%)
70
5 days ago
11/16 (68.75%)
$32.84 (58.48%)
196
Buy
90
$34.34 (61.70%)
90
12 days ago
8/11 (72.73%)
$27.09 (43.06%)
214
Sell
48
$-7.66 (-13.76%)
42
1 months 28 days ago
3/6 (50%)
$-38.06 (-44.22%)
144
Hold
80
$24.34 (43.73%)
61
2 months 1 days ago
9/12 (75%)
$-6.19 (-7.18%)
109
Hold
66
$10.34 (18.58%)
57
2 months 1 days ago
6/8 (75%)
$-20.19 (-23.42%)
217
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
